Skip to main content
. 2021 Apr 17;60(9):1217–1226. doi: 10.1007/s40262-021-01011-3

Table 3.

Parameter estimates. Final pharmacodynamic model

Parameter Description Estimate (95% CI) RSE (%) IIV CV (%) Shrinkage (%)
Kin (ng/mL/h) Zero-order production rate of IGF-I at zero GH levels (estimated) 0.949 (0.411–1.49) 28.9 117 15.1
Kin,endoadult (ng/mL/h) Zero-order production rate of IGF-I at endogenous GH levels for 85-kg adults with GHD (derived) 1.97
Kin,endochild (ng/mL/h) Zero-order production rate of IGF-I at endogenous GH levels for 25-kg children with GHD (derived) 2.22
Kout (1/h) First-order elimination rate of IGF-I 0.0262 (0.0218–0.0306) 8.6 17.4 31.3
EC50 (ng/mL) Somatropin concentration corresponding to half-maximum stimulation of IGF-I production rate 2.13 (1.39–2.88) 17.9
Emaxadult (ng/mL/h) Maximum increase in IGF-I production rate for adults with GHD 15.1 (fixed) 33.1 13.3
θBWEmaxadult Body weight covariate on the maximum increase in IGF-I production rate for adults with GHD 0.46 (fixed)
Emaxchild (ng/mL/h) Maximum increase in IGF-I production rate for children with GHD 6.48 (4.75–8.70) 14.0 33.1 13.3
θBWEmaxchild Body weight covariate on the maximum increase in IGF-I production rate for children with GHD 1.94 (1.05–2.84) 23.5
Proportional error Trial 1 (%) 14.6 9.4
Proportional error Trial 2 (%) 8.7 5.5
Proportional error Trial 3 (%) 11.4 12.0

BW body weight, CI confidence interval, CV coefficient of variation, Emax maximum increase in IGF-I production rate, EC50 GH concentration corresponding to half-maximum stimulation of IGF-I production rate, GH growth hormone, GHD growth hormone deficiency, IGF-I insulin-like growth factor-I, IIV inter-individual variability, Kendo zero-order process for endogenous growth hormone production, Kin zero order production rate of IGF-I, Kout first-order elimination rate of IGF-I, RSE relative standard error